Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform.

MacKenna B, Kennedy NA, Mehrkar A, Rowan A, Galloway J, Matthewman J, Mansfield KE, Bechman K, Yates M, Brown J, Schultze A, Norton S, Walker AJ, Morton CE, Harrison D, Bhaskaran K, Rentsch CT, Williamson E, Croker R, Bacon S, Hickman G, Ward T, Davy S, Green A, Fisher L, Hulme W, Bates C, Curtis HJ, Tazare J, Eggo RM, Evans D, Inglesby P, Cockburn J, McDonald HI, Tomlinson LA, Mathur R, Wong AYS, Forbes H, Parry J, Hester F, Harper S, Douglas IJ, Smeeth L, Lees CW, Evans SJW, Goldacre B, Smith CH, Langan SM

The association of abdominal adiposity with premature discontinuation of postoperative chemotherapy in colon cancer.

Brown JC, Meyerhardt JA, Cespedes Feliciano EM, Cheng E, Caan BJ

Membrane-bound O-acyltransferase 7 (MBOAT7)-driven phosphatidylinositol remodeling in advanced liver disease.

Varadharajan V, Massey WJ, Brown JM

Inhaled silica nanoparticles cause chronic kidney disease in rats.

Sasai F, Rogers KL, Orlicky DJ, Stem A, Schaeffer J, Garcia G, Fox J, Ray MS, Butler-Dawson J, Gonzalez-Quiroz M, Leiva R, Taduri G, Anutrakululchai S, Venugopal V, Madero M, Glaser J, Wijkstrom J, Wernerson A, Brown JM, Johnson RJ, Roncal-Jimenez CA

Effects of hospital facilities on patient outcomes after cancer surgery: an international, prospective, observational study.

GlobalSurg Collaborative and NIHR Global Health Research Unit on Global Surgery.

Excess Growth Hormone Alters the Male Mouse Gut Microbiome in an Age-dependent Manner.

Jensen EA, Young JA, Jackson Z, Busken J, Kuhn J, Onusko M, Carroll RK, List EO, Brown JM, Kopchick JJ, Murphy ER, Berryman DE

Acrolein, an environmental toxicant and its applications to in vivo and in vitro atherosclerosis models: An update.

Crowley LN, Le BL, Cicalo C, Brown J, Li Y, Kim YJ, Lee JH, Pan JH, Lennon SL, Han BK, Kim JK

A real-world US study of recurrence risks using combined clinicopathological features in HR-positive, HER2-negative early breast cancer.

Sheffield KM, Peachey JR, Method M, Grimes BR, Brown J, Saverno K, Sugihara T, Cui ZL, Lee KT

Remyelination in humans due to a retinoid-X receptor agonist is age-dependent.

McMurran CE, Mukherjee T, Brown JWL, Michell AW, Chard DT, Franklin RJM, Coles AJ, Cunniffe NG

Molecular profiles of endometrial cancer tumors among Black patients.

Wilhite AM, Baca Y, Xiu J, Paladugu R, ElNaggar AC, Brown J, Winer IS, Morris R, Erickson BK, Olawaiye AB, Powell M, Korn WM, Rocconi RP, Khabele D, Jones NL